BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33437788)

  • 1. Myeloid cell leukemia-1 is an important predictor of survival and progression of small cell lung cancer.
    Zhou T; Zhang L; Liu T; Yang Y; Luo F; Zhang Z; Huang Y; Zhao H; Zhang L; Zhao Y
    Ann Transl Med; 2020 Dec; 8(23):1589. PubMed ID: 33437788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia defined by skeletal muscle mass index at the third lumbar vertebra is a prognostic factor for extensive-stage small cell lung cancer patients: a retrospective study.
    Wang K; Long W; Sima X; Zhao Y; Xiao B; Gulizeba H; Huang Y
    J Thorac Dis; 2022 Jul; 14(7):2645-2651. PubMed ID: 35928624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
    Huang LL; Hu XS; Wang Y; Li JL; Wang HY; Liu P; Xu JP; He XH; Hao XZ; Jiang PD; Liu YT; Luo J; Zhou SY; Wang JW; Yang JL; Qin Y; Yuan P; Lin L; Shi YK
    Thorac Cancer; 2021 Jul; 12(13):1943-1951. PubMed ID: 33969619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer.
    Nakano T; Go T; Nakashima N; Liu D; Yokomise H
    Anticancer Res; 2020 Feb; 40(2):1007-1014. PubMed ID: 32014946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer].
    Wang B; Feng N; Shi X; Qi Q; Chi X; Song T; Li H
    Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):547-553. PubMed ID: 32702788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study.
    Geng N; Ding CM; Liu ZK; Song S; Hu WX
    Int J Clin Oncol; 2021 Apr; 26(4):670-683. PubMed ID: 33392882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
    He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
    Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
    Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
    Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
    Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
    Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.
    Chen XR; Liang JZ; Ma SX; Fang WF; Zhou NN; Liao H; Li DL; Chen LK
    Onco Targets Ther; 2016; 9():5729-5736. PubMed ID: 27703372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
    He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
    Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid cell leukemia-1 as a candidate prognostic biomarker in cancers: a systematic review and meta-analysis.
    Wang J; He Y; Yang C; Luo Q; Wang B
    Expert Rev Anticancer Ther; 2023; 23(9):1017-1027. PubMed ID: 37467344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib.
    Liu J; Li S; Zhang S; Yang C; Zhang L; Zhang B; Cheng Y; Wang C
    J Thorac Dis; 2020 Oct; 12(10):5765-5773. PubMed ID: 33209408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.
    Lee GW; Go SI; Kim DW; Kim HG; Kim JH; An HJ; Jang JS; Kim BS; Hahn S; Heo DS
    Thorac Cancer; 2020 Jan; 11(1):62-71. PubMed ID: 31707767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
    Ma X; Zhang Z; Chen X; Zhang J; Nie J; Da L; Hu W; Tian G; Wu D; Han J; Han S; Long J; Wang Y; Fang J
    Thorac Cancer; 2021 Jun; 12(12):1841-1850. PubMed ID: 33955685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.
    Sodja E; Rijavec M; Koren A; Sadikov A; Korošec P; Cufer T
    Radiol Oncol; 2016 Jun; 50(2):188-96. PubMed ID: 27247551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer.
    Fu X; Liu Z; Xiang L; Liu M; Zheng X; Wang J; Liu N; Gao H; Jiang A; Yang Y; Liang X; Ruan Z; Tian T; Yao Y
    Cancer Manag Res; 2020; 12():10939-10948. PubMed ID: 33154673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.